• Japanese encephalitis: The virus and vaccines
  • Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine
  • Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012
  • Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis
  • Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age
  • Coxsackievirus A16: Epidemiology, diagnosis, and vaccine

 Japanese encephalitis: The virus and vaccines

Sang-Im Yun and Young-Min Lee

View Article

 Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine

Brigitte Cheuvart, Kathleen M Neuzil, A Duncan Steele, Nigel Cunliffe, Shabir A Madhi, Naveen Karkada, Htay Htay Han and Carla Vinals

View Article

Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012

Yu Bin Seo, Won Suk Choi, Ji Hyeon Baek, Jacob Lee, Joon Young Song, Jin Soo Lee, Hee Jin Cheong and Woo Joo Kim

View Article

 Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis

E Jane Homan and Robert D Bremel

View Article

Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age

Terry M Nolan, Michael D Nissen, Aftab Naz, Julie Shepard, Lisa Bedell, Matthew Hohenboken, Tatjana Odrljin and Peter M Dull

View Article

Coxsackievirus A16: Epidemiology, diagnosis, and vaccine

Qun-Ying Mao, Yiping Wang, Xin Yao, Lianlian Bian, Xing Wu, Miao Xu and Zheng-Lun Liang

View Article

Current Issue

Human Vaccines & Immunotherapeutics

April 2014

Volume 10, Issue 4

View current issue

About the cover image
Three-dimensional reconstructions of HPV11 decorated with antibody fragment H11.B2 B2. For more information see Zhao et al.  

Open Access

Human Vaccines & Immunotherapeutics offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.

Open Access Fees

Research Papers and Reports, OA fee is $750.00 USD

Reviews, Brief Reports and Short Communications, OA fee is $500.00 USD

All other types of papers, OA fee is $250.00

Journal Description

Human Vaccines & Immunotherapeutics is a unique peer-reviewed journal, focused exclusively on vaccines and immunotherapeutics for humans.

Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can help to promote interest by keeping investigators updated as well as to enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.

Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors. Articles cover topics including but not limited to research, development, clinical, regulatory, production, epidemiology, effectiveness, health economics, use in the field, perceptions, acceptance, and safety.

Recent Articles

Most Popular Downloads